Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 1, 2025
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 1, 2025
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will be webcasting its participation in the upcoming conferences: Citizens Life Science Conference in New York, NY …
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
GlobeNewswire
·
May 1, 2025
FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today advises that, as previously disclosed in …
Volatus annonce la clôture d'un placement VIE entièrement souscrit de 3 000 000 $
GlobeNewswire
·
May 1, 2025
Ne pas distribuer aux agences de presse des États-Unis ni diffuser aux États-Unis. TORONTO, 01 mai 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV :FLT) (OTCQX :TAKOF) (Francfort : ABB) (« Volatus » ou la « Société ») est heureuse d'annoncer qu'elle …
THINK AGENT STANDARD LAUNCHES WITH SUPPORT FROM 70+ COMPANIES TO CHALLENGE BIG TECH’S AI MONOPOLY
GlobeNewswire
·
May 1, 2025
SEATTLE, WA, May 01, 2025 (GLOBE NEWSWIRE) -- Thinkagents.ai is proud to announce the beta launch of the Think Agent Standard, a foundational framework for enabling millions of autonomous, on-chain AI agents to transact and communicate. Developed by the …
Volatus Announces Closing of Fully Subscribed LIFE Offering of $3,000,000
GlobeNewswire
·
May 1, 2025
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to …
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 1, 2025
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor …
Endeavour Silver Completes Acquisition of Minera Kolpa
GlobeNewswire
·
May 1, 2025
All dollar amounts are stated in United States (U.S.) Dollars unless otherwise noted. VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce the …
Altai Announces Initiation of Strategic Review
GlobeNewswire
·
May 1, 2025
TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that the Board of Directors (the “Board”) has initiated a strategic review process to identify, evaluate, and pursue a range of potential …
Capital Power reports voting results from the 2025 annual meeting of shareholders
GlobeNewswire
·
May 1, 2025
EDMONTON, Alberta, May 01, 2025 (GLOBE NEWSWIRE) -- The annual meeting of shareholders (“annual meeting”) for Capital Power Corporation (TSX: CPX) (“Capital Power” or “the Corporation”) was held on April 29, 2025. Each of the matters voted upon at the …
Rumble Announces Timing of First Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
May 1, 2025
LONGBOAT KEY, FL, May 01, 2025 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the video-sharing platform and cloud services provider, today announced that it will release financial results for the fiscal quarter ended March 31, …
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
GlobeNewswire
·
May 1, 2025
DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
GlobeNewswire
·
May 1, 2025
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …
MacroGenics to Participate in Upcoming Investor Conference
GlobeNewswire
·
May 1, 2025
ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
GlobeNewswire
·
May 1, 2025
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 1, 2025
– Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE …
Astera Labs Ramps Production of PCIe 6 Connectivity Portfolio Supercharging Advanced AI and Cloud Infrastructure Deployments
GlobeNewswire
·
May 1, 2025
SANTA CLARA, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced its purpose-built PCIe® 6 connectivity portfolio is …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 1, 2025
FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …
Mercury Acquires Star Lab to Advance Its Leadership Position in Secure Processing
GlobeNewswire
·
May 1, 2025
ANDOVER, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing to the edge, today announced the closure of an agreement that will further advance the …
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
GlobeNewswire
·
May 1, 2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug …
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
GlobeNewswire
·
May 1, 2025
iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to Japan Launch is timely amid a …